FDA.reportPublic FDA data

Zilbrysq 16.6 MG (equivalent to zilucoplan sodium 17 MG) per 0.416 ML Prefilled Syringe

RxCUI
2672502
RxNorm name
Zilbrysq 16.6 MG (equivalent to zilucoplan sodium 17 MG) per 0.416 ML Prefilled Syringe
Display name
Zilbrysq 16.6 MG (equivalent to zilucoplan sodium 17 MG) per 0.416 ML Prefilled Syringe
Full name
Zilbrysq 16.6 MG (equivalent to zilucoplan sodium 17 MG) per 0.416 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9f1d53d6-e495-4a3a-8bb9-680a15d25034ZILBRYSQ 16.6 MG in 0.416 ML Prefilled Syringe [PSN] · 0.416 ML zilucoplan 40 MG/ML Prefilled Syringe [Zilbrysq] [SBD] · Zilbrysq 16.6 MG (equivalent to zilucoplan sodium 17 MG) per 0.416 ML Prefilled Syringe [SY]313These highlights do not include all the information needed to use ZILBRYSQ safely and effectively. See full prescribing information for ZILBRYSQ. ZILBRYSQ (zilucoplan) injection, for subcutaneous use Initial U.S. Approval: 202320260203